Similar articles

• Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.

  Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Marusić M, Francetić I, Kastelan A, et al. Mrsić M, et al. Bone Marrow Transplant. 1990 Aug;6(2):137-41. Bone Marrow Transplant. 1990. PMID: 2207450 Clinical Trial.
• Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.

  Shepherd JD, Shore TB, Reece DE, Barnett MJ, Klingemann HG, Buskard NA, Phillips GL. Shepherd JD, et al. Bone Marrow Transplant. 1988 Nov;3(6):553-8. Bone Marrow Transplant. 1988. PMID: 3063323
• Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.

  Truog AW, Wozniak SP. Truog AW, et al. Oncol Nurs Forum. 1990 Jan-Feb;17(1):39-44. Oncol Nurs Forum. 1990. PMID: 2405360 Review.
• [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation--combination protocol of high dose methylprednisolone, prednisolone and methotrexate].

  Shinohara Y, Kai S, Misawa M, Fujimori Y, Okamoto T, Kohsaki M, Kanamaru A, Ifuku H, Ohe Y, Hara H, et al. Shinohara Y, et al. Rinsho Ketsueki. 1986 Jan;27(1):30-5. Rinsho Ketsueki. 1986. PMID: 3520045 Japanese. No abstract available.
• Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.

  Schwinghammer TL, Bloom EJ. Schwinghammer TL, et al. Clin Pharm. 1993 Oct;12(10):736-61. Clin Pharm. 1993. PMID: 8258255 Review.